Electroporation-Mediated Gene Transfer Directly to the Swine Heart

In vivo gene transfer to the ischemic heart via electroporation holds promise as a potential therapeutic approach for the treatment of heart disease. In the current study, we investigated the use of in vivo electroporation for gene transfer using three different penetrating electrodes and one non-penetrating electrode. The hearts of adult male swine were exposed through a sternotomy. Eight electric pulses synchronized to the rising phase of the R wave of the electrocardiogram were administered at varying pulse widths and field strengths following an injection of either a plasmid encoding luciferase or one encoding green fluorescent protein. Four sites on the anterior wall of the left ventricle were treated. Animals were killed 48 h after injection and electroporation and gene expression was determined. Results were compared with sites in the heart that received plasmid injection but no electric pulses or were not treated. Gene expression was higher in all electroporated sites when compared with injection only sites demonstrating the robustness of this approach. Our results provide evidence that in vivo electroporation can be a safe and effective non-viral method for delivering genes to the heart, in vivo.

[1]  B. Demeneix,et al.  Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. , 1993, Human gene therapy.

[2]  H. Aihara,et al.  Gene transfer into muscle by electroporation in vivo. , 1998, Nature biotechnology.

[3]  Leslie Tung,et al.  Electroporation‐mediated gene transfer in cardiac tissue , 1998, FEBS letters.

[4]  S. Epstein,et al.  Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. , 1996, Circulation.

[5]  M. Jaroszeski,et al.  Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo , 2000, Gene Therapy.

[6]  J. Folkman,et al.  Angiogenic therapy of the human heart. , 1998, Circulation.

[7]  K. Barnhart,et al.  A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. V. von Specht,et al.  Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. , 1998, Circulation.

[9]  C. Wheeler,et al.  Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  S. Epstein,et al.  Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. , 1994, Circulation.

[11]  Peipei Ping,et al.  Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heart , 1996, Nature Medicine.

[12]  R. Crystal,et al.  Efficient gene transfer into myocardium by direct injection of adenovirus vectors. , 1993, Circulation research.

[13]  Ralph A. Schmid,et al.  In Vivo Electroporation Mediated Gene Delivery to the Beating Heart , 2010, PloS one.

[14]  R. W. Lau,et al.  The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz. , 1996, Physics in medicine and biology.

[15]  J. Isner,et al.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.

[16]  M J Jaroszeski,et al.  Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression , 2010, Gene Therapy.

[17]  M. Bureau,et al.  High-efficiency gene transfer into skeletal muscle mediated by electric pulses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Epstein,et al.  Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. , 1995, Circulation.

[19]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[20]  E. Furth,et al.  Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Richard Heller,et al.  In vivo electroporation for gene therapy. , 2006, Human gene therapy.

[22]  S. Parker,et al.  Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates. , 1995, Human gene therapy.

[23]  S. Epstein,et al.  Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. , 1994, The American journal of physiology.